Researchers at Texas A&M University have developed a tissue-adhesive biosensor that detects inflammation biomarkers in the mouth with molecular precision, potentially shifting oral healthcare from reactive to proactive.
The FDA approved Zycubo (copper histidinate) on January 13, 2026, as the first treatment for Menkes disease in pediatric patients, following resolution of manufacturing compliance concerns that led to an initial rejection in September 2025.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07470541 |
Viromes in Infants Presenting With a Septic Syndrome |
NOT_YET_RECRUITING | NA |
| NCT06931002 |
A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis |
RECRUITING | NA |
| NCT06488118 |
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848) |
RECRUITING | NA |
| NCT06271655 |
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE) |
ACTIVE_NOT_RECRUITING | NA |
| NCT06149494 |
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection |
COMPLETED | PHASE2 |
| NCT06025682 |
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO |
RECRUITING | |
| NCT05953233 |
School Inner City Air Study |
RECRUITING | NA |
| NCT05902702 |
Isotonic Saline for Children With Bronchiolitis |
NOT_YET_RECRUITING | NA |
| NCT05897801 |
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO |
COMPLETED | |
| NCT05717283 |
Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology. |
COMPLETED | NA |
